Launch of ReFeel® Nerve Repair Solution at ASSH 2024

PBC Biomed are delighted to announce the launch of our client Mochida Pharmaceutical Co., Ltd. innovative new nerve repair product – ReFeel® Nerve Repair Solution.

ReFeel® is #biocompatible in nature and uses a proprietary alginate and PGA formula to create a bridge for #nerve #regeneration. The freeze-dried alginate sheet suppresses the migration and proliferation of cells that make up granulation tissue; providing a protected environment which facilitates the natural healing process of the nerve.

The PBC Biomed Design & Development, Clinical, Regulatory and Commercial teams have been working alongside Mochida Pharmaceutical Co., Ltd. for the last four years; preparing this technology for commercial release.

ReFeel® will officially be launched at the American Society for Surgery of the Hand (ASSH) conference in Minneapolis this week. Visit booth #210 for more information on this exciting new technology!

Caution: Prescription use only. Federal law (USA) restricts this device to sale by or on the order of a physician.

#acceleraratingmedicalinnovation #ASSH24